| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/11/2013 | CN102342921B Pharmaceutical composition of prasugrel hydrobromide acetate compound |
| 09/11/2013 | CN102335302B Externally applied heath care product for treating chronic pelvic inflammatory disease |
| 09/11/2013 | CN102325527B Patch for treating constipation using crude drugs |
| 09/11/2013 | CN102316901B Transdermal preparation |
| 09/11/2013 | CN102307573B Tablets for combination therapy |
| 09/11/2013 | CN102293780B Sodium acetate Ringer's injection and preparation method thereof |
| 09/11/2013 | CN102283816B Silodosin sustained-release tablet and preparation method thereof |
| 09/11/2013 | CN102274467B Method for detecting capsules for treating nodule in breast by dissolving stasis |
| 09/11/2013 | CN102264324B Pressure-sensitive adhesive tape package |
| 09/11/2013 | CN102247316B Hydrophobic coating for controlling drug release and preparation method thereof |
| 09/11/2013 | CN102166236B Oil-in-water type notopterygium oil nano emulsion oral liquid and preparation method thereof |
| 09/11/2013 | CN102138905B RhBMP-2-loaded chitosan microspheres, preparation method thereof and application thereof |
| 09/11/2013 | CN102078411B Preparation method of spreading hedyotis herb injection |
| 09/11/2013 | CN102038963B Method for preparing a stabilised menthol emulsion |
| 09/11/2013 | CN102000341B Polyethylene oxide and matrix type surfactant in suppository composition |
| 09/11/2013 | CN101991538B TPGS-containing liposome composition and application thereof |
| 09/11/2013 | CN101987189B Detoxifying and channel dredging external application powder |
| 09/11/2013 | CN101890169B Moxifloxacin oral preparation and preparation method thereof |
| 09/11/2013 | CN101836978B Solid preparation containing single crystal form |
| 09/11/2013 | CN101829300B Hyperthermia agent with high thermal efficiency and multiple functions |
| 09/11/2013 | CN101822665B Ascaridol gastric retention preparation and preparation method thereof |
| 09/11/2013 | CN101810583B HIV (Human Immunodeficiency Virus) fusion inhibitor slow-release microsphere |
| 09/11/2013 | CN101657190B A biodegradable microsphere composition suitable for the controlled release of glucose controlling peptide and formulation thereof |
| 09/11/2013 | CN101583341B Eyelid scrub composition |
| 09/11/2013 | CN101559241B Hyaluronic acid-hydroxyapatite nano composite sphere and preparation method |
| 09/11/2013 | CN101511339B Anhydrous multiphase gel system |
| 09/11/2013 | CN101378729B Compositions and methods for treating dermatological conditions |
| 09/11/2013 | CN101137350B Gastroresistant pharmaceutical formulations containing rifaximin |
| 09/10/2013 | US8530625 Silk-based drug delivery system |
| 09/10/2013 | US8530507 Use of levo-ornidazole in the preparation of anti-anaerobic bacteria infection drugs |
| 09/10/2013 | US8530481 Stable pharmaceutical composition of freeze-dried tetrodotoxin powder |
| 09/10/2013 | US8530463 Multimodal particulate formulations |
| 09/10/2013 | US8530428 Treating cancer with granulocyte-macrophage colony stimulating factor |
| 09/10/2013 | US8530407 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 09/10/2013 | US8529979 Stable emulsions of oils in aqueous solutions and methods for producing same |
| 09/10/2013 | US8529969 Treatment of the guar split with an alkaline solution and hydrogen peroxide, partial neutralization with acid, removal of peripheral cell layers of the guar split, treating split with aqueous alcohol, grinding; clarity; use as thickener |
| 09/10/2013 | US8529963 Method for preparing dispersions of precious metal nanoparticles and for isolating such nanoparticles from said dispersions |
| 09/10/2013 | US8529957 Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo |
| 09/10/2013 | US8529955 Methods of treatment using a gastric retained gabapentin dosage |
| 09/10/2013 | US8529954 Composition based on gamma-hydroxybutyric acid |
| 09/10/2013 | US8529953 Process for production of spherical microparticles comprising tamsulosin hydrochloride |
| 09/10/2013 | US8529952 improved bioavailabilty; micronized fenofibrate, a surfactant and a binding cellulose derivative as a solubilization adjuvant |
| 09/10/2013 | US8529950 Magnesium system and use thereof in the cosmetics industry |
| 09/10/2013 | US8529949 Pharmaceutical tablets of crystalline type II aripiprazole |
| 09/10/2013 | US8529948 Pharmaceutical formulation containing gelling agent |
| 09/10/2013 | US8529947 Alkaloid formulations |
| 09/10/2013 | US8529946 Rapidly disintegrating antihistamine formulation |
| 09/10/2013 | US8529945 Oral antimicrobial pharmaceutical compositions |
| 09/10/2013 | US8529944 Targeted delivery to human diseases and disorders |
| 09/10/2013 | US8529941 Free-standing biodegradable patch |
| 09/10/2013 | US8529939 Purified protein(s) combined with drug(s) and biocompatible solvent(s) to form a coatable mixture; reduction to form a cohesive body or solidified cohesive mass that is formed into a mucoadhesive device havinghomogenous distribution; ovalbumin combined with glycerol; bonding strength |
| 09/10/2013 | US8529936 Long term drug delivery devices with polyurethane based polymers and their manufacture |
| 09/10/2013 | US8529927 Alpha-2 agonist polymeric drug delivery systems |
| 09/10/2013 | US8529920 Low pH retinoid topical compositions |
| 09/10/2013 | US8529917 Micelle encapsulation of a combination of therapeutic agents |
| 09/10/2013 | US8529916 High concentration baclofen preparations |
| 09/10/2013 | US8529914 Bioactive dose having containing a material for modulating pH of a bodily fluid to help or hinder absorption of a bioactive |
| 09/10/2013 | US8529890 Composition for the administration of polymeric drugs |
| 09/10/2013 | US8529875 Tobacco alkaloid releasing chewing gum |
| 09/10/2013 | US8529807 Heat treatment; reconditioning sheet-, wafer- or film-like forms of drugs, confectionary, food, cosmetics for oral administration |
| 09/10/2013 | US8529553 Infusion medium delivery device and method with drive device for driving plunger in reservoir |
| 09/10/2013 | US8529552 Apparatus, system and method for administration of a substance |
| 09/10/2013 | US8529551 Acoustically controlled substance delivery device |
| 09/10/2013 | US8529550 Implant delivery catheter system and methods for its use |
| 09/10/2013 | CA2731769C Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders |
| 09/10/2013 | CA2683698C A biodegradable microsphere composition suitable for the controlled release of glucose controlling peptide and formulation thereof |
| 09/10/2013 | CA2671449C Composite material for tissue repair |
| 09/10/2013 | CA2648473C Impact of calcium phosphate complex on dental caries |
| 09/10/2013 | CA2645763C Calcium phosphate complex in acid containing confectionery |
| 09/10/2013 | CA2633125C Adhesive pharmaceutical preparation containing bisoprolol |
| 09/10/2013 | CA2616081C Gastroretentive formulations and manufacturing process thereof |
| 09/10/2013 | CA2611430C Pharmaceutical compositions of a neuroactive steroid and uses thereof |
| 09/10/2013 | CA2610987C Stabilizer for protein preparation comprising meglumine and use thereof |
| 09/10/2013 | CA2610414C Skin patch |
| 09/10/2013 | CA2608457C Ebselen as a prophylactic or therapeutic agent for corneal or conjunctival disorders |
| 09/10/2013 | CA2601340C Improvements relating to rapidly dissolving compositions |
| 09/10/2013 | CA2595894C Percutaneously absorbable preparation, percutaneously absorbable preparation holding sheet, and percutaneously absorbable preparation holding equipment |
| 09/10/2013 | CA2586597C Multiparticulate pharmaceutical form comprising mucoadhesively formulated nucleic acid active ingredients, and a process for producing the pharmaceutical form |
| 09/10/2013 | CA2584401C Food supplement containing fish oil |
| 09/10/2013 | CA2578574C Compositions for delivering highly water soluble drugs |
| 09/10/2013 | CA2427340C Cyp1b1 nucleic acids and methods of use |
| 09/10/2013 | CA2272245C Stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies |
| 09/06/2013 | WO2013130785A2 Extended release pharmaceutical formulations of water-soluble active pharmaceutical ingredients and methods for making the same |
| 09/06/2013 | WO2013130767A1 Inhalable dry powders |
| 09/06/2013 | WO2013130766A1 Spray dried formulations |
| 09/06/2013 | WO2013130669A1 Pharmaceutical composition and administration thereof |
| 09/06/2013 | WO2013130584A2 Formulation containing ws727713 |
| 09/06/2013 | WO2013130535A1 Topical delivery of hormonal and non hormonal nano formulations, methods of making and using the same |
| 09/06/2013 | WO2013130449A1 Phosphoramidite compositions |
| 09/06/2013 | WO2013130433A1 Composition for oral delivery of veterinary drugs and supplements to animals |
| 09/06/2013 | WO2013129936A1 Use of an antibody and a particulate immunomodulator in therapy |
| 09/06/2013 | WO2013129935A1 Use of a particulate immunomodulator in cancer therapy |
| 09/06/2013 | WO2013128453A1 Regeneration of islet beta cells by hsp60 derived peptides |
| 09/06/2013 | WO2013128276A2 Tamper resistant immediate release formulations |
| 09/06/2013 | WO2013127949A1 Functional pla-peg copolymers, the nanoparticles thereof, their preparation and use for targeted drug delivery and imaging |
| 09/06/2013 | WO2013127831A1 Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer |
| 09/06/2013 | WO2013127830A1 Tamper-resistant pharmaceutical dosage form comprising nonionic surfactant |
| 09/06/2013 | WO2013127728A1 Hormone containing emulsion |
| 09/06/2013 | WO2013127727A1 Hormone containing emulsion comprising krill phospholipids |
| 09/06/2013 | WO2013127004A1 Polymeric nanoparticles useful in theranostics |